Image Ben Hargreaves Patients Gilead's HIV success and controversy: Expanding access amid ... Gilead has grown to become a leader in the fight against HIV and has announced efforts to improve access to a new, highly effective medicine. Oncology Beyond COVID-19: mRNA vaccines aim to revolutionise cancer c... mRNA vaccines, pivotal in the fight against COVID-19, are now emerging as a promising innovation in cancer treatment. Market Access Inflation Reduction Act proves positive boost for biosimilar... For the pharma industry, the IRA has made headlines due to it allowing price negotiations on top-selling treatments. R&D Weight loss gold rush: Developers vie for next blockbuster t... Weight loss treatments are rapidly becoming a focal point for pharma R&D, driven by the commercial success of Eli Lilly and Novo Nordisk’s therapies. Load more results
Patients Gilead's HIV success and controversy: Expanding access amid ... Gilead has grown to become a leader in the fight against HIV and has announced efforts to improve access to a new, highly effective medicine.
Oncology Beyond COVID-19: mRNA vaccines aim to revolutionise cancer c... mRNA vaccines, pivotal in the fight against COVID-19, are now emerging as a promising innovation in cancer treatment.
Market Access Inflation Reduction Act proves positive boost for biosimilar... For the pharma industry, the IRA has made headlines due to it allowing price negotiations on top-selling treatments.
R&D Weight loss gold rush: Developers vie for next blockbuster t... Weight loss treatments are rapidly becoming a focal point for pharma R&D, driven by the commercial success of Eli Lilly and Novo Nordisk’s therapies.
News Gene therapy firm Kate Tx snapped up by Novartis for $1.1bn Novartis buys gene therapy specialist Kate Therapeutics for $1.1 billion, adding an early-stage rival to Sarepta's muscular dystrophy therapy Elevidys
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends
